Spring heralds new beginnings, and joyous news keeps pouring in! As the year of the Horse 2026 unfolds, Tianji Quan Group has received a significant announcement: after rigorous review, on-site verification, and comprehensive evaluation by the Shenzhen SME Service Bureau, the group has successfully retained its designation as a "Specialized, Refined, Distinctive, and Innovative" SME in Shenzhen. This honor not only reflects the official recognition of Tianji Quan Group's sustained dedication to specialized, refined, distinctive, and innovative development, but also further demonstrates the group's innovative capabilities, industry competitiveness, and brand credibility. It lays a solid foundation for the group's high-quality development in the year of the Horse and injects new momentum into the high-quality growth of the health industry.

Tianji Quan Group has been consecutively recognized as a "Specialized, Refined, Distinctive, and Innovative" enterprise in Shenzhen

The "Specialized, Sophisticated, Distinctive, and Innovative" small and medium-sized enterprises in Shenzhen are exemplary SMEs whose core business aligns with national industrial policies, exhibit prominent "Four Modernizations" characteristics, possess strong innovation capabilities, and demonstrate outstanding development quality and efficiency. They also serve as a crucial driving force for high-quality economic and social development.

Tianji Quan Group has been consecutively recognized as a "Specialized, Refined, Distinctive, and Innovative" enterprise in Shenzhen

Since its establishment in 2001, Tianjiquan Group, under the leadership of Chairman and CEO Shi Yanbao, has always focused on cutting-edge health technology, adhered to the core strategy of technological innovation and product research and development, and has been continuously cultivating for more than 20 years. The group continues to integrate high-quality resources, gather high-tech research talents, and rely on core products such as QRS quantum resonance health information detector and G SLT semiconductor laser therapy device to lead the green health field and become the preferred brand in the national healthcare and medical field.

The board of directors of Tianjiquan Group attaches great importance to product innovation and research and development

Standing at a new starting point, Tianjiquan Group will be led by a "specialized, refined, and innovative" enterprise, continuously deepen independent innovation, make breakthroughs in specialization, refinement, specialization, and novelty, increase research and development efforts in quantum medical technology, continuously improve the level of health services, and consolidate core competitive advantages. In the future, Tianjiquan Group will continue to support the high-quality development of Healthy China and the big health industry, and work together to realize Tianjiquan's dream of making all humanity healthy, creating greater value for society.